Navigation Links
Adoption of Spinal Nonfusion Technologies Doubled in One Year
Date:4/24/2008

From Q4 2006 to Q4 2007, artificial disc and dynamic stabilization nonfusion segments skyrocketed, according to Millennium Research Group's US

Spine Marketrack(TM) data

WALTHAM, Mass., April 24 /PRNewswire/ -- Millennium Research Group's (MRG) US Spine Marketrack(TM) results indicate that a growing number of facilities are adopting nonfusion technologies. Rising patient and surgeon awareness and new product releases starting in Q3 2007 added to this growth and will facilitate ongoing increases in the market going forward.

In Q4 2006, just over 6% of hospitals surveyed performed artificial disc procedures, but by Q4 2007, this proportion doubled to over 13%. Similarly, the number of facilities that performed dynamic stabilization treatments also doubled from 10% to 20% over the same time frame.

Products like Medtronic Spinal and Biologics' Prestige-ST and the X-STOP, Synthes Spine's ProDisc-C and ProDisc-L, DePuy Spine's Charite, and Zimmer Spine's Dynesys, as well as new devices entering the market, are experiencing growing adoption rates. Manufacturers are increasingly training surgeons on nonfusion technologies, such as artificial discs and dynamic stabilization devices, facilitating this adoption. Surgeons are finding these technologies are more in tune with the body because they preserve motion as opposed to fusion technologies, which result in reduced movement of the spine.

"Patients are excited about nonfusion technology," says Kevin Flewwelling, Manager of MRG's Orthopedics division. "Not only do they benefit from increased motion preservation, but the recovery times are shorter, enabling them to return quickly to their regular lifestyles."

Millennium Research Group will be attending the American Association of Neurological Surgeons (AANS) Annual Meeting in Chicago on April 28-30. To meet MRG at the AANS or get a preview of US Spine Marketrack(TM) data, please contact MRG.

About Arti
'/>"/>

SOURCE Millennium Research Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. IC Sciences Launches ICS Alliance to Advance Development and Adoption of Informatics Instruments for Next Generation Healthcare
2. Novo Nordisk Applauds Adoption of World Diabetes Day Resolutions by U.S. Congress
3. YM Biosciences announces adoption of renewed Shareholders Rights Plan
4. Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord
5. Families of Spinal Muscular Atrophy; University of California, Irvine Stem Cell Scientist; and California Stem Cell Announce Collaboration for Safety Studies for Stem Cell Therapy in Spinal Muscular Atrophy
6. Ranier Technology Secures GBP8m Funding for its Cadisc Replacement Spinal Discs
7. Microchip Biotechnologies, Inc. Enters Into License Arrangement With GE Healthcare for Fundamental Microfluidic Patents
8. VNUS Medical Technologies Reports First-Quarter 2008 Results: 21% growth in Net Revenues and 51% Growth in Unit Sales
9. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
10. Emisphere Technologies To Hold Annual Stockholders Meeting on May 8, 2008
11. Neptune Technologies & Bioressources Inc. reports third quarter results and update on strategic milestones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015  Ceres, Inc. (Nasdaq: CERE ), an ... for a genetic sequence derived from soybean, covering uses ... development and plant transformation. The company believes that its ... are the target of a class of commercial herbicides. ... license to the innovation, including an opportunity for exclusivity ...
(Date:5/26/2015)... OTTAWA, Canada, and BELLINGHAM, Washington, USA (PRWEB) May 26, ... has signed a formal partnership with the ... Ottawa Centre for Extreme and Quantum Photonics. The center ... in the field of photonics, and will be only ... Arthurs, CEO of SPIE, the international society for ...
(Date:5/26/2015)... and HILDEN, Germany ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... its QIAGEN Clinical Insight ® (QCI™) bioinformatics ... to interpret and report on genomic variants identified ... applications for the bioinformatics platform are in oncology, ...
(Date:5/26/2015)... Global Stem Cells Group and ... company’s first cellular and regenerative medicine symposium in Barcelona ... hands-on stem cell training class Oct. 10. The event ... President of Therapeutic Confrontations (CONFTERA) in Barcelona. , ... regenerative medicine and recent advances in cellular therapies, Global ...
Breaking Biology Technology:Ceres Awarded Patent for Innovation in Soybean 2Ceres Awarded Patent for Innovation in Soybean 3Third Max Planck Centre in North America Inaugurated at University of Ottawa 2Third Max Planck Centre in North America Inaugurated at University of Ottawa 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 2QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 4QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 5Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 2Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 3
... use, reliability and ... convenience, ... availability of easypod(R), the first of its kind,automated device in the ... [somatropin (rDNA origin) for,injection], the company,s treatment for growth hormone deficiency. ...
... proteins in their natural environment and interactions inside ... advanced microscopy technique called cryo-electron tomography, researchers from ... proteins responsible for cell-cell contacts for the first ... publish the first 3D image of human skin ...
... (NYSE: SGP ) was honored by Scrip ... industry awards: Large Pharma Company,of the Year, Management ... Year for,Fred Hassan, Schering-Plough chairman and CEO., ... and achievement,within the pharmaceutical and biotech industries. Scrip ...
Cached Biology Technology:Video and Photo: EMD Serono Launches easypod(R), New Electronic Growth Hormone Injection Device 2Video and Photo: EMD Serono Launches easypod(R), New Electronic Growth Hormone Injection Device 3Video and Photo: EMD Serono Launches easypod(R), New Electronic Growth Hormone Injection Device 4The closest look ever at native human tissue 2Schering-Plough Wins Three of Scrip's Top Pharma Industry Awards 2
(Date:5/11/2015)... RYE, N.Y. , May 11, 2015 ... company, announced the start of a new Phase III ... effect of its novel formulation, CM-AT, on all children ... results of its FDA Phase III double blinded clinical ... who had low levels of the digestive enzyme chymotrypsin. ...
(Date:5/6/2015)... TEL AVIV, Israel , May 6, 2015 /PRNewswire/ ... the world,s most established helmet producer, announced today that ... LifeBEAM Smart Helmet, the world,s first bio-sensing cycling helmet ... will be released in two new colors in order ... demand for the product. In addition, LifeBEAM and Lazer ...
(Date:4/27/2015)... FORT LAUDERDALE, Fla. , Apr. 27, 2015 /PRNewswire/ ... provider of access control and security systems is pleased ... joined the company as a consultant and member of ... Bedore is widely known as a thought leader ... Socrates Distance Learning Technology Group, and has published studies ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... by scientists at McGill University and the University of Zurich ... their ability to signal information. The research may explain why ... a specially formulated diet. The findings, published Jan. 16 ... processes that inhibit brain activity, such as that involved in ...
... This news release is available in French ... 2014 When it comes to global warming, there are seven ... the United Kingdom. A new study published in Environmental Research ... than 60 per cent of pre-2005 global warming. Uniquely, it also ...
... 15, 2014 MedNet Solutions , a global life ... pleased to announce that the latest version of ... iMedNet user community.  iMedNet EDC provides an ... to Sponsors and CROs wanting to quickly and easily build ...
Cached Biology News:How metabolism and brain activity are linked 2Global warming's biggest offenders 2MedNet Solutions Announces Latest Release Of Its Innovative iMedNet EDC eClinical Solution 2
Human VEGF R3/Flt-4 Phycoerythrin MAb (Clone 54733)...
Immunogen: Synthetic Peptide: V(22) N G H E F E I E G E G E G R(36) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Human beta IG-H3 MAb (Clone 348506) Keywords: BIGH3, betaIG-H3 Protein Family: Extracellular Matrix Molecules...
Human Siglec-9 Biotinylated Affinity Purified Pab...
Biology Products: